Precigen, Inc.
PGEN
$6.10
-$0.39-6.01%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1,866.84% | 652.01% | 148.18% | 60.77% | -0.07% |
| Total Other Revenue | -258.33% | -253.33% | -- | 40.00% | 44.00% |
| Total Revenue | 1,875.05% | 652.08% | 146.73% | 59.20% | -1.12% |
| Cost of Revenue | -18.56% | -20.18% | -19.50% | -46.50% | -40.79% |
| Gross Profit | 200.69% | 77.36% | 31.72% | 51.13% | 42.99% |
| SG&A Expenses | 72.18% | 81.19% | 69.83% | 56.52% | 23.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.75% | 25.23% | 17.90% | 14.76% | -0.63% |
| Operating Income | 58.18% | 3.11% | -12.56% | -12.91% | 0.61% |
| Income Before Tax | -26.60% | -29.04% | -95.77% | -74.40% | 9.36% |
| Income Tax Expenses | 100.00% | 100.17% | 100.17% | 95.88% | 96.50% |
| Earnings from Continuing Operations | -26.67% | -30.49% | -98.55% | -76.88% | 8.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.67% | -30.49% | -98.55% | -76.88% | 8.04% |
| EBIT | 58.18% | 3.11% | -12.56% | -12.91% | 0.61% |
| EBITDA | 61.51% | 3.36% | -14.66% | -16.77% | -3.70% |
| EPS Basic | -154.83% | -116.59% | -190.15% | -155.65% | 20.77% |
| Normalized Basic EPS | -19.89% | -42.42% | -122.20% | -116.83% | -15.29% |
| EPS Diluted | -156.22% | -116.61% | -190.17% | -155.67% | 20.75% |
| Normalized Diluted EPS | -21.70% | -42.42% | -122.20% | -116.83% | -15.29% |
| Average Basic Shares Outstanding | 18.40% | 17.66% | 16.92% | 16.00% | 16.05% |
| Average Diluted Shares Outstanding | 23.30% | 17.66% | 16.92% | 16.00% | 16.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |